Drug-Induced Reduction in 80Q Aggregates in a Dictyostelium discoideum Model of PolyQ Disease
Abstract
Background/Objectives: Polyglutamine (polyQ) expansion induces protein misfolding, aggregation, and neurodegeneration; however, effective strategies for aggregate clearance remain limited. This study evaluated the effect of metformin, resveratrol, and curcumin on polyQ proteotoxicity using an engineered Dictyostelium discoideum model expressing 80Q repeats, and investigated their autophagy-related mechanism. Methods: In this study, 80Q-expressing Dictyostelium discoideum (D. discoideum) cells were treated with metformin, resveratrol, or curcumin. Cell viability and proliferation were assessed by growth curve and doubling-time analyses. Developmental assays examined restoration of multicellular morphology. PolyQ aggregation was analyzed using brightfield microscopy, fluorescence microscopy, Thioflavin T (ThT), and Congo Red assays. Quantitative real-time polymerase chain reaction (qRT-PCR) evaluated AMP-activated protein kinase (AMPK) and autophagy-related gene expression. Molecular docking and molecular dynamics (MD) simulations were performed to assess interactions between the compounds and AMPK. Results: All three compounds significantly improved viability and reduced doubling time in 80Q-expressing cells. Treated strains displayed improved developmental morphology and culmination compared to untreated controls. Thioflavin T (ThT) and Congo Red assays demonstrated a marked reduction in amyloid-like polyQ aggregates following treatment. Gene-expression analysis revealed the…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.